Familial AD (Alzheimer's disease) is a rare autosomal dominant form of AD, associated with clinical and pathological features similar to those identified in the more prevalent sporadic AD cases. The majority of familial AD cases are caused by mutations in either of the highly homologous PS (presenilins), an essential component of the γ -secretase enzyme complex, or amyloid precursor protein, a γ -secretase substrate and the precursor of amyloid β peptides. The observation that PS are absolutely required for γ -secretase activity, and parallel studies demonstrating that PS interact with several signalling molecules, modulate their stability or regulate their proteolysis, have led to the suggestion that involvement of PS in additional signalling pathways mediating key cellular functions may contribute to the pathogenesis and progression of neurodegeneration. In this paper, we review PS-regulated molecules, their role in cell signalling and possible involvement in neurodegeneration in patients suffering from AD.
Involvement of presenilins in cell-survival signalling pathways Introduction
The pathogenesis of AD (Alzheimer's disease) is complex, being associated with much molecular, cellular and physiological pathology. The primary causative events associated with the pathogenesis of AD are the generation of Aβ (amyloid β) peptide, which is proteolytically derived from APPs (amyloid precursor proteins) and neurofibrillar tangles, composed of the aggregated, hyperphosphorylated microtubule-associated protein tau. Their predominance as pathologies associated with AD has led to the 'amyloidcascade hypothesis' and 'tau hypothesis', which state that Aβ and hyperphosphorylated tau are the initiating biochemical events that culminate in neurotoxicity and neurodegeneration in sporadic and familial AD. The most compelling evidence in support of these hypotheses comes from the identification of genes that either cause or enhance the risk of developing AD. Most of these genes modulate some aspect of Aβ production, while others, particularly the PS (presenilins), modulate both the formation of Aβ and phosphorylation of tau [1, 2] . However, it is now emerging that PS are multifunctional proteins having pivotal roles in the regulation of several cellsignalling events independent of previously reported ADassociated activities; this has led to the proposal that aberrant biological activities of PS within signalling complexes may be related to the pathogenesis of neurodegenerative processes in AD [3] [4] [5] .
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PS-interacting proteins
Subsequent to the identification of PS and their functional involvement in the pathogenesis of familial AD, many research groups have shown, using yeast two-hybrid or coimmunoprecipitation approaches, that PS interact with a diverse and ever increasing list of proteins centrally involved in regulating γ -secretase activity, cell survival, development and signalling events (Table 1) [4] . In some cases, the biological significance of the association with PS is not obvious, although some of the PS-interacting proteins can be subdivided into functional groups, including those involved in the γ -secretase protein complex, Wnt signalling, cellcell adhesion, vesicular transport, apoptosis and calcium signalling ( Table 1) .
The γ -secretase protein complex
Studies that supported the opinion that PS-NTF/CTF heterodimers (where NTF stands for N-terminal fragment and CTF for C-terminal fragment) constitute the catalytic subunit of γ -secretase [6] led to biochemical studies aimed at purifying γ -secretase activity. These studies concluded that PS involvement in γ -secretase activity requires the incorporation of the PS-NTF/CTF heterodimer into highmolecular-mass protein complexes of 250-1000 kDa, which contain at least three additional PS-binding molecules/ cofactors: nicastrin, Aph-1 and Pen-2 [1, 7, 8] . Subsequent studies have shown that, initially, nicastrin and Pen-2 bind and stabilize PS-holoprotein in a low-molecular-mass complex, and subsequent recruitment of Pen-2 induces endoproteolysis of PS and activation of the γ -secretase highmolecular-mass complex [9] . These five components, PS-NTF, PS-CTF, nicastrin, Pen-2 and Aph-1, define a group of functionally conserved proteins essential for the assembly and activity of PS-mediated γ -secretase complexes. Whether [57] there are more components essential for the γ -secretase activity in mammalian cells remains to be determined.
PS and Wnt signalling
From the demonstrated importance of β-catenin in Wnt signal transduction, cell adhesion and tumour progression, extensive research has been performed on the characterization of the interaction between PS and members of the armadillorelated proteins such as β-catenin, γ -catenin, δ-catenin, p0001 and neural-specific plakophilin ( Table 1) . The interaction between PS1 and β-catenin is regulated by phosphorylation of PS1 by cyclin-dependent kinase 5 and GSK-3β (glycogen synthase kinase-3β) [10, 11] . β-Catenin has a central role in transmitting Wnt-ligand-mediated signalling, which leads to stabilization and nuclear translocation of β-catenin, where it associates with LEF (lymphoid enhancer factor)/TCF (Tcell factor) transcription factors to activate Wnt target genes. In the absence of Wnt, β-catenin is phosphorylated by two sequential kinase activities. First, phosphorylation by casein kinase-1α coupled with the axin complex, 'primes' for a second phosphorylation by GSK-3β, which targets β-catenin for proteosomal degradation. It is proposed that the interaction between PS1 and β-catenin allows PS1 to function in parallel with the Wnt pathway to promote degradation of β-catenin by acting as a scaffold to mediate GSK-3β phosphorylation of β-catenin after priming by a different kinase. Independent studies demonstrated that cells expressing familial AD-linked PS variants have defective intracellular trafficking of β-catenin, while cells from PS-null animals exhibit higher cytosolic β-catenin levels and elevated β-catenin-mediated LEF/TCF signalling, resulting in the activation of the downstream target cyclin D1 and accelerated entry into the S-phase of the cell cycle [12] . Consistent with this report, in transgenic mice, disruption of PS1-β-catenin interaction results in aberrant regulation of β-catenin-mediated signalling and a skin tumour phenotype [13] . Disruption of the interaction between β-catenin and PS1 does not affect PS stability, endoproteolysis or Aβ generation, suggesting that the PS-β-catenin interaction is unlikely to participate in PS biology [10] . Likewise, pharmacological inhibition of γ -secretase activity or expression of catalytically inactive PS variants does not affect PS-β-catenin interactions, trafficking, stabilization or transcriptional activity, suggesting its independence from traditional γ -secretase functions [10] . Independent studies have demonstrated that PS1 interacts with the serine/threonine kinase; GSK-3β and familial ADlinked PS variants can attenuate this interaction and inhibit GSK-3β activity [14] . Absence of PS1 or the expression of familial AD-linked PS variants is associated with increased GSK-3β activity, hyperphosphorylation of the microtubule-associated protein tau, enhanced kinesin lightchain phosphorylation and a parallel reduction in kinesinbased axonal transport [15] . Recently, it was demonstrated that (GSK-3α) inhibitors could attenuate Aβ production in cell cultures, mechanistically involving direct γ -secretase inhibition [16] .
PS and protein localization
PS are ubiquitously expressed and their subcellular localization in neurons and peripheral tissues has provided an insight into their potential functions. The localization of PS in the ER (endoplasmic reticulum) and Golgi and the effects of familial AD-linked PS mutations on protein processing and localization are compatible with a role for PS in protein sorting or trafficking in cells. Independent observations have described an interaction between PS and several proteins involved in vesicle transport (Rab11, RabGDI and syntaxin 5) [17] [18] [19] , protein sorting (IRE1) [20] or degradation (ubiquilin and HC5/ZETA) [21, 22] . In addition to localization in the ER and Golgi, PS-NTF/CTF hetrodimers have been localized at synaptic plasma membranes, synaptic adhesion sites and neurite growth cones. PS localization at synaptic plasma membranes may be through an association with syntaxin 1A [23] , and localization at synaptic adhesion sites through an association with cadherin-catenin protein complexes that regulate the formation of synapses and co-ordinate synaptic strength [24, 25] . Both cadherins and β-catenin are associated with proteins that form the synaptic complex and disruption of this function alters dendritic spine morphology, impairs synaptic vesicle accumulation and recycling, and affects the distribution of post-synaptic proteins. Induction of apoptosis or increased cytosolic calcium concentrations stimulates PSmediated γ -secretase cleavage of E-cadherins, resulting in disassembly of the E-cadherin-catenin adhesion complex. As a consequence, the cytosolic domain of E-cadherin and the associated β-catenin are released into the cytosol [26] . Whether this redistribution of β-catenin serves as a mechanism to increase cytosolic β-catenin and subsequent LEF/TCF signalling remains to be determined.
PS and apoptosis
Following the identification of familial AD-linked PS variants, several laboratories have demonstrated that the expression of familial AD-linked PS mutants induced cell death or increased susceptibility to insults that lead to apoptosis [4] . Confirmation of a role for PS in apoptosis came from the demonstration that PS2-CTF rescued cells from T-cell receptor-and Fas-induced cell death. Another study demonstrated that a deficiency of PS1 caused an increased vulnerability to H 2 O 2 -induced apoptosis while expression of PS1 suppressed H 2 O 2 -induced apoptosis and also suggested that PS1 inhibits apoptosis by inhibiting the SAPK (stressactivated protein kinase)/JNK (c-Jun N-terminal kinase) pathway. This inhibitory effect of PS1 is potentially mediated by an interaction with QM/Jif-1, a negative regulator of c-jun [27] .
Subsequently, a convincing role for PS in neurodegeneration was provided from studies using animals in which both PS1 and PS2 were conditionally deleted. These studies demonstrated age-associated neuronal death accompanied by deficits in learning, memory and synaptic function. The mechanisms underlying this familial AD-associated or age-dependent neurodegeneration are unclear; however, the finding that PS interact with members of the anti-apoptosis Bcl-2 family of proteins may indicate a potential mechanism by which PS might modulate apoptosis [28, 29] . Similarly, it has recently been demonstrated that PS interact with and modulate the activity of the proapoptotic mitochondrial protease Omi, released from the mitochondria during apoptosis [30] . However, so far it has not been demonstrated whether increased susceptibility to apoptosis associated with loss of PS1 or expression of familial AD-linked PS mutations can be attributed to altered interactions with Omi or Bcl-2 homologues.
PS and calcium homoeostasis
Although PS do not contain any calcium-binding motifs, both forms of PS have been shown to interact with several calciumrelated proteins, such as calsenilin, sorcin and calmyrin [4, [31] [32] [33] [34] [35] . An independent study demonstrated that IP 3 (inositol trisphosphate)-mediated intracellular calcium release was specifically enhanced in patients with AD, while neither voltage-dependent calcium influx nor release of ER calcium stores was different for AD and control fibroblasts. Several subsequent studies have provided convincing evidence suggesting that PS are involved in the regulation of calcium homoeostasis [31] . Enhanced basal phosphoinositide hydrolysis and exaggerated release of calcium from IP 3 -dependent ER stores has been observed in cells expressing familial AD-linked PS mutants and in neurons derived from transgenic mice expressing a familial AD-linked PS1 mutation. Co-expression of calsenilin with familial AD-linked PS variants has been shown to reverse the potentiation of IP 3 -induced calcium release in Xenopus oocytes expressing familial AD-linked PS mutants. Exaggerated elevations in intracellular calcium concentrations are also observed in cells expressing familial AD-linked PS variants and in primary fibroblasts and neurons derived from familial AD-linked PS mutant knock-in embryos, following trophic factor withdrawal or exposure to Aβ peptides. Inevitably, cells expressing familial AD-linked PS variants show increased susceptibility to Aβ toxicity and increased vulnerability to cell death. Likewise, PS-mediated regulation of calcium homoeostasis also affects glutamate uptake and glutamateinduced calcium responses in neurons. Collectively, these independent observations suggest a proapoptotic mechanism involving the destabilization of calcium homoeostasis as a means of increasing the vulnerability to apoptosis of cells expressing familial AD-linked PS variants [4, 31] .
Independent reports have also demonstrated that PS modulate CCE (capacitative calcium entry), a mechanism that regulates the coupled process of IP 3 -mediated release of ER calcium and replenishing intracellular calcium stores through plasma-membrane channels [4, 31, 36] . Absence of PS1 enhances CCE, while familial AD-linked PS mutants antagonize CCE. A physiological role for PS1 regulation of CCE in neuronal synaptic transmission has been demonstrated in studies showing that calcium influx by the CCE mechanism in PS-null animals, but not in wild-type neurons, is sufficient to trigger long-term potentiation [36] .
PS and regulated intramembrane proteolysis
PS-mediated γ -secretase activity was initially characterized due to its involvement in the generation of Aβ and was later found to mediate Notch signalling [37] . Recently, several more γ -secretase substrates have been identified, indicating that PS have a generic role in regulated intramembrane proteolysis of certain membrane proteins, whereby cells can relay signals from the extracellular space to their interiors through PS-dependent proteolysis within or close to the transmembrane domain of type-I integral membrane proteins, to generate potentially active intracellular signalling fragments [3, 5, [37] [38] [39] . Ligand binding to the Notch receptor results in cleavage of the receptor extracellular domain (ectodomain shedding) by TACE [tumour necrosis factor α-converting enzyme] and subsequent intramembrane cleavage by γ -secretase. The membrane-released NICD [Notch ICD (intracellular domain)] migrates to the nucleus and binds to the Re family transcription factor, CSL (C-promoterbinding factor/recombination signal-sequence binding protein Jκ/suppressor-of-Hairless/Lag1) [3, 39] . This interaction allows the recruitment of the cofactor Mastermind, and switches CSL from a repressor to activator of transcription, which results in the expression of Notch-targeted genes.
The identification of NICD-mediated gene transcription prompted further research involving the APP-derived AICD (APP ICD) and several laboratories have now demonstrated that AICD serves an additional signalling function through an association-induced stabilization and potentiation of the nuclear adaptor protein FE65. Binding of FE65 to the histone acetyltransferase, Tip60, results in displacement of the nuclear co-repressor-associated-complex and transcriptional activation of the tetraspanin protein KAI1 [39] .
Cell-based assays have now shown that several other γ -secretase-generated receptor fragments potentially function in the regulation of gene transcription [39] . The N-cadherinderived ICD can decrease CREB (cAMP-response-elementbinding protein)-dependent transcription by inducing the degradation of CBP (CREB-binding protein). Jagged-derived ICD can induce the expression of an AP-1 (activator protein-1)-reporter gene and the CD44 receptor-derived ICD can induce the activation of a PMA-responsive element and the LRP (low-density-lipoprotein-receptor-related protein)-derived ICD inhibits transcription activity of an APPGal4-binding domain fusion construct. Nuclear localization of the nerve growth factor receptor-derived and ERB4-derived ICDs have also been reported; however, whether these receptor-derived ICDs can regulate gene transcription remains to be determined [39] .
Summary
AD-associated mutations in the PS alter APP cleavage and Aβ production, but in addition, they are functionally required for neuronal homoeostasis and survival, neuronal signalling, maintenance of calcium homoeostasis, protein stability and trafficking and cognitive function. Antagonizing the production of Aβ by modulating or inhibiting PS-mediated γ -secretase activity is currently being vigorously pursued as one of the potential therapeutic strategies for the treatment of AD. However, disruption or loss of γ -secretase function disrupts many essential physiological processes, leading to early lethality in several organisms. In transgenic animals, the absence of PS is associated with a predominant Notch knockout phenotype and inhibition of Notch-mediated signalling, highlighting the importance of PS in development. Furthermore, the recently acquired knowledge that PSmediated γ -secretase cleavage is involved in the generation of numerous ICDs with signalling capabilities, and the accumulating evidence that PS interact with several signalling molecules functioning in a diversity of signalling pathways mediating an array of cellular functions, demands caution in pursuing this therapeutic strategy. Several antagonists that inhibit γ -secretase and lower Aβ production while also binding PS-NTF/CTF heterodimers have been reported. Some of these inhibitors broadly antagonize γ -secretase, while the characterizations of others indicate that it is possible to develop selective inhibitors that uniquely target APP cleavage and Aβ production. The studies reviewed in this paper highlight how aberrant regulation of PS activities in cell signalling might affect cell survival and speculate on how some may contribute to neurodegeneration. Conclusive evidence demonstrating that alterations in any of these signalling events can affect neuronal dysfunction or loss in AD is still lacking, but the studies reviewed emphasize the important need to characterize further the γ -secretase-dependent and -independent mechanisms that function in mediating the variety of PS functions, such as regulation of Aβ production and also other cellular functions.
